Compare Injective (INJ) vs Zilliqa (ZIL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Zilliqa — how do they compare? Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,78T 24h volume), while Zilliqa trades at Rp54.49 (market cap Rp1,09T, Rp53,89M 24h volume). The key difference: Injective is far larger — about 8.5× Zilliqa's market cap, and Zilliqa's supply is capped (20,1B / 21B ZIL (96%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Zilliqa for 129 Days on average.
| INJ | ZIL | |
|---|---|---|
Market Cap | Rp9,29T | Rp1,09T |
Volume (24h) | Rp1,78T | Rp53,89M |
Circulating Supply | 100M INJ | 20,1B / 21B ZIL (96%) |
Typical Hold Time | 36 Days | 129 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Zilliqa (ZIL) is trading at Rp54.615 with a market cap of Rp1.09T, showing a bearish technical signal from moving averages while oscillators remain neutral. The token is near its pivot point of Rp54, with immediate resistance at Rp55. No major protocol updates or ecosystem developments were noted recently. Trading volume and network activity appear subdued, with a circulating supply of 20.1M out of 21M ZIL.
Overall outlook is cautious due to bearish technicals and lack of positive catalysts. Key opportunities include potential rebounds from support levels, while risks involve low liquidity and broader crypto market volatility. Investors should monitor for any network upgrades or exchange developments that could impact sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Zilliqa
Zilliqa (ZIL) is a public, permissionless blockchain that is designed to offer high throughput with the ability to complete thousands of transactions per second. It seeks to solve the issue of blockchain scalability and speed by employing sharding as a second-layer scaling solution. The platform is home to many decentralized applications, and as of October 2020, it also allows for staking and yield farming.
Read more on ZIL →
